Product NDC: | 49884-665 |
Proprietary Name: | Morphine Sulfate |
Non Proprietary Name: | Morphine Sulfate |
Active Ingredient(s): | 20 mg/1 & nbsp; Morphine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-665 |
Labeler Name: | Par Pharmaceutical Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200812 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111110 |
Package NDC: | 49884-665-11 |
Package Description: | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (49884-665-11) |
NDC Code | 49884-665-11 |
Proprietary Name | Morphine Sulfate |
Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (49884-665-11) |
Product NDC | 49884-665 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Morphine Sulfate |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20111110 |
Marketing Category Name | ANDA |
Labeler Name | Par Pharmaceutical Inc. |
Substance Name | MORPHINE SULFATE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |